Cytosorbents Corp expected to post a loss of 6 cents a share - Earnings Preview

Cytosorbents

28/03/2025 20:25

Cytosorbents Corp CTSO.OQ CTSO.O is expected to show a rise in quarterly revenue when it reports  results on March 31 for the period ending December 31 2024

The Princeton New Jersey-based  company is expected to report a 16.5% increase in revenue to $10.1 million from $8.67 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Cytosorbents Corp is for a loss of 6 cents per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Cytosorbents Corp is $7.00​, above​ its last closing price of $1.00. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.06
-0.06
-0.04
Beat
36.8
Jun. 30 2024
-0.09
-0.10
-0.08
Beat
17.9
Mar. 31 2024
-0.12
-0.12
-0.12
Met
0​
Dec. 31 2023
-0.10
-0.14
-0.13
Beat
5.5
​​Sep. 30 2023
-0.15
-0.14
-0.21
Missed
-52.2
Jun. 30 2023
-0.11
-0.11
-0.14
Missed
-24.4​
Mar. 31 2023
-0.13
-0.13
-0.17
Missed
-34.2
Dec. 31 2022
-0.18
-0.17
-0.02
Beat
88.1

This summary was machine generated March 28 at 20:25 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)